Trends in organ preservation

Transplant International

Volumn 16, Issue 10, 2003, Pages 701-708

  McLaren, Andrew James ^a   Friend, Peter John ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Preservation; Transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL BLOCKING AGENT; DRUG ADDITIVE; FLUOROCARBON; HEAT SHOCK PROTEIN; LAZAROID; PFITHRIN ALPA; PRESERVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

CELL SWELLING; CELL VIABILITY; CRYOPRESERVATION; DNA MODIFICATION; GENETIC MANIPULATION; GRAFT INJURY; GRAFT SURVIVAL; HUMAN; ION TRANSPORT; ISCHEMIA; MACHINE PERFUSION TECHNOLOGY; MEDICAL TECHNOLOGY; NORMOTHERMIC PERFUSION; ORGAN DONOR; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; ORGAN VIABILITY; PANCREAS PRESERVATION; PERFUSION; PRESERVATION TECHNOLOGY; PRIORITY JOURNAL; REVIEW; WARM PERFUSION;

COLD; HUMANS; ISCHEMIA; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0242391065     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2003.tb00227.x     Document Type: Review

References (63)

1. Porte R, Ploeg R, Hansen B, Bockel Jv, Thorogood J, Persijn G, et al. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 1998; 11[Suppl 1]: 164-167
2. Morris P, Johnson R, Fuggle S, Belger M, Briggs J. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999; 354: 1147-1152
3. Cho Y, Terasaki P, Cecka J, Gjertson D. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998; 338: 221-225
4. Metcalfe M, Butterworth P, White S, Saunders R, Murphy G, Taub N, et al. A Case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation 2001; 71: 1556-1559
5. Rudich S, Kaplan B, Magee J, Arenas J, Punch J, Kayler L, et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future. Transplantation 2002; 74: 1715-1720
6. Sicular A, Moore F. The post mortem survival of tissues. The effect of time and temperature on the survival of liver as measured by glucose oxidation rate. J Surg Res 1961; 1: 16
7. Mcanulty J, Ametani M, Southard J, Belzer F. Effect of hypothermia on intracellular Ca2+ in rabbit tubules suspended in UW-gluconate preservation solution. Cryobiology 1996; 33: 196-204
8. Polyak MM, Arrington BO, Stubenbord WT, Boykin J, Brown T, Jean-Jacques MA, Estevez J, Kapur S, Kinkhabwala M. The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation 2000; 69: 249-258
9. Land W, Schneeberger H, Schleibner S, Illner W, Abendroth D, Rutili G, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211-217
10. Nishida T, Morita S, Miyamoto K, Masuda M, Tominaga R, Kawachi Y, Yasui H. The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-h heart preservation. A study based on a working model using cross-circulated blood-perfused rabbit hearts. Transplantation. 1996 Jan 27; 61: 194-9
11. Shackleton CR, Ettinger SL, Scudamore CH, Toleikis PF, Keown PA. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischemia. J Surg Res. 1994 Oct; 57: 433-7
12. Todo S, Hamada N, Zhu Y, Zhang S, Subbotin V, Nemoto A, Takeyoshi I, Starzl TE. Lazaroid U-74389G for 48-h canine liver preservation. Transplantation. 1996 Jan 27; 61: 189-94
13. Huang H, Patel PB, Salahudeen AK. Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: potential explanation for the lack of efficacy of lazaroids in clinical trials. Pharmacol Res. 2001 Jan; 43: 55-61
14. Burns A, Davies D, McLaren A, Cerundolo L, Morris P, Fuggle S. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 1998; 66: 872-876
15. Jassem W, Fuggle S, Rela M, Koo D, Heaton N. The role of mitochondria in ischaemia/reperfusion injury. Transplantation 2002; 73: 493-499
16. Korge P, Langer G. Mitochondrial Ca2+ uptake, efflux and sarcolemmal damage in Ca2+ overloaded cultured rat cardiomyocytes. Am J Physiol 1998; 274: H2085
17. Steinlechner-Maran R, Eberl T, Kunc M, Schrocksnadel H, Margreiter R, Gnaiger E. Respiratory defect as an early event in preservation-reoxygenation injury of endothelial cells. Transplantation 1997; 63: 136
18. Sasaki S, Yasuda K, McCully J, LoCicero J. Calcium channel blocker enhances lung preservation. J Heart Lung Transplan 1999; 18: 127-132
19. Ramella-Virieux S, Steghens J, Barbieux A, Zech P, Pozet N, Hadj-Aissa A. Nifedipine improves recovery function of kidneys preserved in a high-sodium, low-potassium cold-storage solution: study with isolated perfused rat kidney technique. Nephrol Dial Transplant 1997; 12: 449-455
20. Tenschert W, Harfmann P, Meyer-Moldenhauer W, Arndt R, Klosterhalfen H. Kidney protective effect of diltiazem after renal transplantation with long cold-ischaemia time and triple-drug immunosuppression. Transplant Proc 1991; 23: 1334-1335
21. Matsumoto K, Honda K, Kobayashi N. Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival. Transplantation 2001; 71: 862-868
22. Kuroda Y, Hiraoka K, Tanioka Y, et al. Role of adenosin in preservation by the two-layer method of ischemically damaged canine pancreas. Transplantation 1994; 57: 1017-1020
23. Lakey J, Tsujimura T, Shapiro A, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002; 74: 1809-1811
24. Matsumoto S, Rigley T, Qualley S, al e. Efficacy of oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from non-human primate and human pancreata. Cell Transplant: in press
25. Kuroda Y, Kawamura T, Tanioka Y, Morita A, Hiraoka K, Matsumoto S, et al. Heart preservation using a cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Transplantation 1995; 59: 699-701
26. Tsujimura T, Suzuki Y, Takahashi T, Yoshida I, Fujino Y, Tanioka Y, et al. Succeesful 24-h preservation of canine small bowel using the cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Am J Transplant 2002; 2: 420-4
27. Chen W, Bennett C, wang M, Dragun D, Tian L, Stecker K, et al. Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 anti-sense oligodeoxynucleotides prevents ischemic/reperfusion injury. Transplantation 1999; 68: 880-7
28. Stepkowski S. Development of anti-sense oligodeoxynucleotides for transplantation. Curr Opin Mol Ther 2000; 2: 304-317
29. Stepkowski S, Chen W, Bennett C, Condon T, Stecker K, Tian L, et al. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplant Proc 2001; 33: 3705-3706
30. Haug C, Colvin R, Delmonico F, Auchinloss H, Tolkoff-Rubin N, Preffer F, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766-772
31. Matsuyama M, Akioka K, Okamoto M, Kadotani Y, Nakamura K, Ushigome H, et al. Control fo renal ischemic reperfusion injury by antisense oligodeoxynuclotide of tissue factor. Transplant Proc 2003; 35: 103-104
32. Ushigome H, Sano H, Okamoto M, Kadotani Y, Nakamura K, Akioka K, et al. The role of tissue factor in renal ischemic reperfusion injruy of the rat. J Surg Res 2002; 102: 102-9
33. Fuller B, Pegg D. The assessment of renal preservation by normothermic bloodless perfusion. Cryobiology 1976; 13: 1033-1044
34. Schon M, Kollmar O, Wolf S, Schrem H, Matthes M, Akkoc N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001; 233: 114-123
35. Imber C, Peter SS, Cenarruzabeitia I, Pigott D, James T, Taylor R, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73: 701-709
36. Brasile L, Stubenitsky B, Booster M, Lindell S, Araneda D, Buck C, et al. Overcoming severe renal ischaemia: the role of ex vivo warm perfusion. Transplantation 2002; 73: 897-901
37. Butler A, Rees M, Wight D, Casey N, Alexander G, White D, et al. Successful extracoporeal porcine liver perfusion for 72 h. Transplantation 2002; 73: 1212-1218
38. Valero R, Cabrer C, Oppenheimer F, Trias E, Sanchez-Ibanez J, Cabo F, et al. Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int 2000; 13: 303-310
39. Gomez M, Alvarez J, Arias J, Barrio R, Muguerza J, Balibrea J, et al. Cardiopulmonary bypass and profound hypothermia as a means for obtaining kidney grafts from irreversible cardiac arrest donors: Cooling technique. Transplant Proc 1993; 24: 1501-1502
40. Koyama I, Ogawa N, Watanabe T, Taguchi Y, Asami H, Nagashima N, et al. Utilisation of warm ischemic livers from non-heart beating donors by portable cardiopulmonary bypass and heterotopic transplantation. Transplant Proc 1996; 28: 1878-1879
41. Saunders A, Ogle M, Ewy G. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med 1985; 3: 11-14
42. Shirakura R, Matsuda H, Nakata S, Kaneko M, Miyagawa S, Fukushima N, et al. A new method to harvest multiple organs from non-heart beating donors by use of a percutaneous cardiopulmonary support machine. Transplant Proc 1992; 24: 1329-1330
43. Watanabe T, Koyama I, Taguchi Y, Ogawa N, Omoto R. Salvage of warm ischemic pancreas from non-heart-beating donors by a core-cooling method with cardiopulmonary bypass. Transplant Proc 1992; 24: 1331-1332
44. Nishinaka T, Tatsumi E, Taenaka Y, Katagiri N, Ohnishi H, Shioya K, et al. At least thirty-four days of animal continuous perfusion by a newly developed extracorporeal membrance oxygenation system without systemic anticoagulants. Artif Organs 2002; 26: 548-551
45. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305: 147-148
46. Cohen M, Baines C, Downey J. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62: 79-109
47. Lee H, Emala C. Protein kinase C and G(i/o) proteins are involved in adenosine and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 2001; 12: 233-240
48. Yadav S, Sindram D, Perry D, Clavien P. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis though a caspase-dependent pathway. Hepatology 1999; 30: 1223-1232
49. Clavien P, Yadav S, Sindram D, Bentley R. Protective effects of ischemic preconditioning for resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162
50. Redaelli CA, Tien YH, Kubulus D, Mazzucchelli L, Schilling MK, Wagner AC. Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 2002 Apr; 90: 489-97
51. McCormick PH, Chen G, Tierney S, Kelly CJ, Bouchier-Hayes DJ. Clinically applicable thermal preconditioning attenuates leukocyte-endothelial interactions. J Am Coll Surg. 2003 Jul; 197: 71-8
52. Ritossa F. A new puffing pattern induced by temperature shock and DNP in Drosophila. Experentia 1962; 18: 571-573
53. Hiratsuka M, Yano M, Mora B, Nagahiro I, Cooper J, Patterson G. Heat shock pretreatment protects pulmonary isografts from subsequent ischemia-reperfusion injury. J Heart Lung Transplant 1998; 17: 1238-1246
54. Perdrizet G, Kaneko H, Buckley T, Fishman M, Pleau M, Bow L, et al. Heat shock and recovery protects renal allografts from warm ischemic injury and enhances HSP72 production. Transplantat Proc 1993; 25: 1670-1673
55. Kelly K, Baird N, Greene A. Induction of stress response proteins and experimental ischemia/reperfusion. Kid Int 2001; 59: 1798-1802
56. Redaelli C, Tien Y, Kubulus D, Mazzucchelli L, Schilling M, Wagner A. Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 2002; 90: 489-497
57. Meldrum K, Burnett A, Meng X, Misseri R, Shaw M, Gearhart J, et al. Liposomal delivery of heat shock protein 72 into tubular cells blocks nuclear factor-kappaB activation, tumour necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 2003; 92: 293-9
58. Wang C, Zuo X, Carpenter D, Jordan S, Nicolaidou E, Toyoda M, et al. Prolongation of cardiac allograft survival with intracoronary viral interleukin-10 gene transfer. Transplant Proc 1999; 31: 951-952
59. Olthoff K, Judge T, Gelman A, Shen Xd, Hancock W, Turka L, et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med 1998; 4: 194-200
60. Swenson K, Ke B, Wang T, Markowitz J, Maggard M, Spear G, et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 1998; 65: 155-160
61. Poston R, Ennen M, Pollard J, Hoyt E, Billingham M, Robbins R. Ex vivo gene therapy prevents chronic vascular disease in cardiac allografts. J Thorac Cardiovasc Surg 1998; 100: 2035
62. Fry J, Morris P, Wood K. Adenoviral transfer of a single donor-specific MHC Class I gene to recipient bone marrow cells can induce specific immunological tolerance. Gene Ther 2002; 9: 220-226
63. Brasile L, Stubenitsky B, Booster M, Arenada D, Haisch C, Kootstra G. Transfection and transgene expression in a human kidney during ex vivo warm perfusion. Transplant Proc 2002; 34: 2624